BSG and Stroke: In the logistic regression, higher levels of CD147 at 24 hours after stroke was significantly and independently associated with greater likelihood of a negative outcome 12 months after stroke as measured by a Modified Rankin scale (mRS) ≥2 (on a six point scale with 0 representing no residual deficits, to 6 representing death).